Aldeyra Therapeutics Inc ALDX:NASDAQ

Last Price$2.46NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change-0.18(6.82%)
Bid (Size)$2.20 (5)
Ask (Size)$5.44 (4)
Day Low / High$2.45 - 2.62
Volume629.7 K

Aldeyra Says Reproxalap Demonstrates Symptom Improvement Over Xiidra in Mid-Stage Trial in Dry Eye Disease

9:51AM ET 1/11/2022 MT Newswires
Aldeyra Therapeutics (ALDX) said Tuesday that patient-reported ocular discomfort and itching were "statistically lower" with reproxalap compared with Xiidra in a phase 2 trial in patients with dry eye disease.

In addition, results showed no moderate or serious adverse events related to the drug, with no safety signals observed, the company said.

Aldeyra shares were marginally lower in morning trading.

Price: 3.83, Change: -0.01, Percent Change: -0.26